Related Experiment Video
Updated: Jul 18, 2025

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection
Published on: May 9, 2022
Is non-contrast MRI sufficient to detect meningioma residue after surgery?
S Motillon Alonso1, F Lersy1, F D Ardellier2
1Radiology 2 Department, Strasbourg University Hospital, Hautepierre Hospital, Strasbourg, France.
Background:
Contrast-enhanced magnetic resonance imaging (MRI) is the imaging modality routinely used to follow up patients who have undergone surgical resection of brain meningiomas. There are growing concerns about the massive use of gadolinium-based contrast agents (GBCA). Our aim was to evaluate the performance of a new imaging protocol, performed without GBCA injection, in the detection of tumoral residue or local recurrence after surgery of parafalcine and convexity meningiomas.
Materials And Methods:
Only adult patients with a documented resected parafalcine or convexity meningioma were included. We performed a dedicated MRI protocol that included non-contrast and post-contrast sequences. The presence or absence of residue on the unenhanced sequences was independently recorded by three observers: first blindly, then in comparison with a baseline enhanced MRI examination.
Results:
A total of 51 patients were included. 37 of them featured a tumor residue on the reference enhanced sequence. Overall, an average of 32 of 37 (87%) residues were identified on the unenhanced sequences that were blindly reviewed; and more than 34 of 37 (93%) were identified with the help of the comparative baseline enhanced examination, with a high sensitivity. The missed cases were related to small residues.
Conclusion:
Unenhanced MRI sequences are highly sensitive and specific in identifying a tumor residue or a local recurrence in the post operative follow up of brain meningiomas. Sensitivity is even higher with the help of a comparative baseline enhanced MRI examination, whatever the strength of magnetic field.
Insights
Unenhanced MRI effectively detects brain tumor remnants after surgery. This method shows high sensitivity, especially when compared to baseline enhanced scans, reducing the need for gadolinium-based contrast agents.
Area of Science:
- Neuroradiology
- Oncology Imaging
Background:
- Contrast-enhanced MRI is standard for brain meningioma follow-up.
- Concerns exist regarding gadolinium-based contrast agent (GBCA) use.
- Alternative imaging protocols are needed.
Purpose of the Study:
- Evaluate a non-GBCA MRI protocol for detecting post-surgical meningioma residue.
- Assess sensitivity and specificity of unenhanced MRI sequences.
Main Methods:
- Included adult patients with resected parafalcine/convexity meningiomas.
- Utilized a dedicated MRI protocol with non-contrast and post-contrast sequences.
- Three observers assessed residue presence on unenhanced vs. enhanced scans.
Main Results:
- 51 patients included; 37 had tumor residue.
- Unenhanced sequences identified 87% of residues blindly.
- Identification increased to 93% with comparative baseline enhanced MRI.
- Missed residues were typically small.
Conclusions:
- Unenhanced MRI is highly sensitive and specific for post-operative meningioma follow-up.
- Comparative baseline enhanced MRI further improves detection rates.
- This approach minimizes GBCA exposure in routine follow-up.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI

